Search terms
Results 1 - 10 of 51 - ordered by :
Pages: 1 2 3 4 5 6 ... 6

Amsterdam, The Netherlands – Monday 2 September 2013: TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to research presented at the ESC Congress ...

Date : 02/09/2013

Sophia Antipolis, France: Tuesday 14 June : The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of ...

Date : 14/06/2011

[...]the guidelines state: ‘Patients should be evaluated and managed at an early stage in a reference centre, with immediate surgical facilities and the presence of a multidisciplinary team, ...

Date : 02/09/2015

Transfemoral access reduces mortality, strokes and bleeding in transcatheter aortic valve implantation (TAVI) compared to the transapical approach, according to a study of more than 10 000 patients ...

Date : 31/08/2014

Better treatment options for preventing cardiovascular disease are needed, particularly in very high risk patients such as those with diabetic complications. “The correlation between lower ...

Date : 29/08/2017

On Thursday 14 April the European Association for Cardiovascular Prevention and Rehabilitation (EACPR) will host joint sessions including a session looking at the medical, legal and ethical aspects ...

Date : 05/04/2011

The beneficiaries were Keith Fox, British Heart Foundation Duke of Edinburgh Professor of Cardiology at the University of Edinburgh, Richard L Popp, Emeritus Professor of Cardiovascular Medicine at ...

Date : 30/08/2015

Gothenburg, Sweden: Two trials presented at the Heart Failure Congress 2011,   organized by the Heart Failure Association of the European Society of Cardiology (HFA of the ESC), will help to define ...

Date : 22/05/2011

(1) Their publication, say the authors, comes at a time when the risk of cardiovascular disease in pregnancy continues to rise in developed countries, mainly because of today's older age at first ...

Date : 26/08/2011

[...]most registry studies suggest a lower risk of death or myocardial infarction with drug eluting stents. The original SCAAR study published 2007 indicated a higher mortality after the initial six ...

Date : 30/08/2009